Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adoptive immunotherapy for primary lung cancer

T Chou1, H Yoshizawa

  • 1Department of Medicine (II), Niigata University Medical School.

Internal Medicine (Tokyo, Japan)
|April 1, 1995
PubMed
Summary

Adoptive immunotherapy with IVS cells and alpha CD3-AT cells shows potential for primary lung cancer patients. Further research is needed to optimize this cancer treatment for broader clinical use.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unilateral flapping tremor associated with internal carotid artery stenosis: -A subtype of limb shaking.

European journal of neurology·2018
Same author

Successful perioperative haemostatic management of aortic coarctation in a 5-week-old infant with severe haemophilia A.

Haemophilia : the official journal of the World Federation of Hemophilia·2017
Same author

Comparable outcomes between autologous and allogeneic transplant for adult acute myeloid leukemia in first CR.

Bone marrow transplantation·2016
Same author

Trends of survival in patients with multiple myeloma in Japan: a multicenter retrospective collaborative study of the Japanese Society of Myeloma.

Blood cancer journal·2015
Same author

The basolateral nucleus of the amygdala mediates caloric sugar preference over a non-caloric sweetener in mice.

Neuroscience·2015
Same author

Randomized phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations: NEJ005/TCOG0902.

Annals of oncology : official journal of the European Society for Medical Oncology·2015

Area of Science:

  • Oncology
  • Immunotherapy

Background:

  • Lung cancer remains a leading cause of cancer-related mortality worldwide.
  • Adoptive immunotherapy offers a promising avenue for cancer treatment by harnessing the patient's immune system.

Purpose of the Study:

  • To evaluate the therapeutic efficacy of adoptive immunotherapy using IVS cells and alpha CD3-AT cells in primary lung cancer patients.
  • To identify potential strategies for enhancing the effectiveness of adoptive immunotherapy for lung cancer.

Main Methods:

  • A clinical trial was conducted involving primary lung cancer patients.
  • Patients received adoptive immunotherapy utilizing IVS cells and alpha CD3-AT cells.

Main Results:

  • The study demonstrated potential therapeutic efficacy in selected patient groups.
  • Specific patient subgroups showed positive responses to the treatment.

Conclusions:

  • Adoptive immunotherapy with IVS cells and alpha CD3-AT cells may be beneficial for certain lung cancer patients.
  • Further research is required, including gene modification of effector cells and combination with active immunization (tumor vaccines), to fully utilize this approach for lung cancer treatment.

Related Experiment Videos